The Central Bank of Cuba approves 10 enterprises to use cryptocurrency for international payments
Foresight News reported, according to Cuban media outlet Cubadebate, that the Central Bank of Cuba (BCC) has, for the first time, approved 10 companies (including 9 small and medium-sized enterprises and 1 joint venture) to use cryptocurrency for international payments. The licenses are valid for 1 year and can be renewed. The companies may only use crypto assets for cross-border payments related to their main business and must operate through Virtual Asset Service Providers (VASP) licensed by the Central Bank of Cuba. Additionally, they are required to report transaction amounts, used currencies, and intermediary service provider information to regulators on a quarterly basis.
Since 2021, the Central Bank of Cuba has regulated virtual assets. In April 2022, the use of Bitcoin and other cryptocurrency platforms was permitted, but always required official authorization. This is the first time Cuban companies have received licenses to directly conduct international payment business.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
"Gold bracelets out of stock"! Shuibei gold, foreign tourists group-buying shopping
Analyst Gu Jingci: Follow the trend and adapt flexibly

XRP Ledger adds account control feature, enabling enterprises to manage assets offline.

BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals
October 9 – Goldman Sachs pointed out that India's implementation of a 30% profit margin cap on non-scheduled anticancer drugs (link) will have limited impact on hospitals. The report states that, based on preliminary discussions with hospital chain groups, such drugs account for less than 5% of hospital revenue and 2% to 2.5% of operating profit. The report adds that hospitals can offset the losses by slightly adjusting service charges, such as administration fees. According to a government notice, an expert committee will finalize the list of drugs to be brought under regulation. Driven by the anticipated price cap, the share prices of Max Healthcare MAXE.NS, Apollo Hospitals APLH.NS, and Fortis Healthcare FOHE.NS rose by 1.6% to 2.5%. Previously, since September 30, these stocks had collectively declined by 11% to 11.5%. Year-to-date, FOHE and MAXE are down 11.7% and 14.8%, respectively, while APLH has risen by 11%. (To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. Due to potential errors or missing context in automated translations, Reuters does not guarantee the accuracy of automatic translation texts and offers them solely for readers’ convenience. Reuters accepts no responsibility for any damage or loss caused by using these automated translation features.)

